계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Overview
- Gender
- male
- Investor Type
- Investment Partner
David Schenkein is a General Partner at GV and was a CEO at Agios Pharmaceuticals. He attended Wesleyan University and State University of New York Upstate Medical University.
Jobs
Number of Current Jobs
4
David Schenkein has 4 current jobs including
Board Observer at Resilience
,
Board Member at Prime Medicine
and
Member of the Board of Directors at Blueprint Medicines
.
| Organization Name | Title At Company | Start Date | End Date | |
|---|---|---|---|---|
Resilience
|
Board Observer | Nov 1, 2020 | — | Detail |
Prime Medicine
|
Board Member | — | — | Detail |
Blueprint Medicines
|
Member of the Board of Directors | — | — | Detail |
Bluebird Bio
|
Member of the Board of Directors | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
